ELITE PHARMACEUTICALS INC /NV/
Retained, source-linked public records. Missing information does not imply that the company has no such information.
Security directory snapshot: 2026-11-17T01:30:34.911Z (not the page refresh time).
Company information and sources
CIK 0001053369
- Official website
- Not verified
- Business description
- Not verified
- Industry and source classification
- Not verified
- Jurisdiction of incorporation
- SEC DEI — Nevada
Evidence observed: 2026-11-03T13:16:16.652Z
Profile content revised: 2026-11-12 · Evidence - Business jurisdiction
- Not verified
- Country (consistent scope not assumed)
- Not verified
Specific securities
- ELTP — Common shares · Filing date: 2026-11-03 · Security evidence
Market classification: Not verified
Classifications belong to individual securities. No principal security is selected for a company with multiple securities.
Retained announcements and disclosures
- · ELTP · Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2027 ended · Original SEC filing
- · ELTP · ELITE PHARMACEUTICALS INC /NV/ files quarterly financial statements for the period ended 2026-09-30 · Original SEC filing
- · ELTP · Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update · Original SEC filing
- · ELTP · Elite Pharmaceuticals Expands Board of Directors with Election of Aqeel A. Fatmi, Ph.D., and John W. LaRocca, Esq. · Original SEC filing
Open the complete company page and existing modules
Additional modules retain their existing access rules and may load separately.